Takeda Pharmaceutical Co Ltd TKD-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 10:47 AM CET
29.19quote price arrow up+0.16 (+0.55%)
Volume
340
52 week range
25.00 - 29.81
Loading...
  • Open29.08
  • Day High29.19
  • Day Low29.08
  • Prev Close29.10
  • 52 Week High29.81
  • 52 Week High Date01/24/23
  • 52 Week Low25.00
  • 52 Week Low Date06/21/22

Key Stats

  • Market Cap49,418.99M
  • Shares Out1,554.52M
  • 10 Day Average Volume808.64
  • Dividend1.24
  • Dividend Yield4.25%
  • Beta-
  • YTD % Change1.35

KEY STATS

  • Open29.08
  • Day High29.19
  • Day Low29.08
  • Prev Close29.10
  • 52 Week High29.81
  • 52 Week High Date01/24/23
  • 52 Week Low25.00
  • 52 Week Low Date06/21/22
  • Market Cap49,418.99M
  • Shares Out1,554.52M
  • 10 Day Average Volume808.64
  • Dividend1.24
  • Dividend Yield4.25%
  • Beta-
  • YTD % Change1.35

RATIOS/PROFITABILITY

  • EPS (TTM)0.97
  • P/E (TTM)30.09
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2022
  • Div Amount90.00
  • Split Date-
  • Split Factor-

Latest On Takeda Pharmaceutical Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric...
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe Weber
President, Chief Executive Officer, Representative Director
Costa Saroukos
Chief Financial Officer, Director
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan